Head and Neck Cancer
📧 Sign up to get email alerts when something new happens for Head and Neck Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2022-03-17Clinical Trial Update: Involved Field Elective Volume De-Intensification Radiation Therapy for Head and Neck Cancer [Phase 2]
Phase 2 trial update on de-intensification radiation therapy targeting involved-field in head and neck squamous cell carcinoma; results post…
-
CLINICAL_TRIALS trial_result · 2022-03-09Clinical Trial Update: Study of Cabiralizumab in Combination With Nivolumab in Patients With Selected Advanced Cancers [Phase 1]
Phase 1 trial assessing cabiralizumab with nivolumab in selected advanced cancers has completed with posted results.
-
CLINICAL_TRIALS trial_result · 2022-03-04Clinical Trial Update: Medpulser Electroporation With Bleomycin Study to Treat Posterior Head and Neck Squamous Cell Carcinoma [Phase 3]
Phase 3 trial update for Medpulser electroporation with bleomycin in posterior head and neck squamous cell carcinoma; study terminated.
-
CLINICAL_TRIALS trial_result · 2022-03-04Clinical Trial Update: Medpulser Electroporation With Bleomycin Study to Treat Anterior Head and Neck Squamous Cell Carcinoma [Phase 3]
Phase 3 trial update for Medpulser electroporation with bleomycin in head and neck cancer has been terminated.
-
CLINICAL_TRIALS trial_result · 2022-01-25Clinical Trial Update: Low-Level Laser in Treatment of Head and Neck Lymphedema: A Pilot Study [NA]
Pilot study evaluating low-level laser therapy for head and neck lymphedema; completed with results posted in 2022.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2022-01-14Clinical Trial Update: Surgery With or Without Adjuvant Stereotactic Body Radiotherapy [NA]
Clinical trial comparing surgery with or without adjuvant stereotactic body radiotherapy for head and neck cancer has completed and posted r…
-
CLINICAL_TRIALS trial_result · 2022-01-11Clinical Trial Update: Nivolumab in Recurrent or Metastatic Salivary Gland Carcinoma of the Head and Neck [Phase 2]
Phase 2 clinical trial update for nivolumab in recurrent or metastatic salivary gland carcinoma of the head and neck has completed.
-
CLINICAL_TRIALS trial_result · 2022-01-10Clinical Trial Update: PD-L1 ImagiNg to prediCt Durvalumab Treatment Response in HNSCC [Phase 1, Phase 2]
Phase 1/2 trial investigating PD-L1 imaging to predict Durvalumab response in head and neck cancer has completed.
-
CLINICAL_TRIALS trial_result · 2022-01-03Clinical Trial Update: Efficacy and Safety Trial of ADU-S100 and Pembrolizumab in Head and Neck Cancer [Phase 2]
Phase 2 trial evaluating ADU-S100 with pembrolizumab in metastatic or recurrent head and neck cancer was terminated with posted results in 2…
-
CLINICAL_TRIALS trial_result · 2021-12-13Clinical Trial Update: A Dose Escalation Study Of PF-06801591 In Melanoma, Head And Neck Cancer (SCCHN), Ovarian, Sarcoma, Non-Small Cell Lung Cancer, Urothelial Carcinoma or Other Solid Tumors [Phase 1]
A Phase 1 dose-escalation study of PF-06801591 in multiple solid tumors including melanoma, head and neck cancer, ovarian cancer, sarcoma, n…
-
CLINICAL_TRIALS trial_result · 2021-11-29Clinical Trial Update: TRYHARD: Radiation Therapy Plus Cisplatin With or Without Lapatinib in Treating Patients With Head and Neck Cancer. [Phase 2]
Phase 2 trial evaluating radiation therapy plus cisplatin with or without lapatinib in non-HPV locally advanced head and neck cancer; comple…
-
CLINICAL_TRIALS trial_result · 2021-11-26Clinical Trial Update: Ph 2 Intensification Regimen for Previously Untreated, Resectable, Advanced Squamous Cell Cancer [Phase 2]
Phase 2 trial update on intensification regimen for previously untreated, resectable, advanced squamous cell head and neck cancer; study ter…
-
CLINICAL_TRIALS trial_result · 2021-11-08Clinical Trial Update: A Phase I/II Study of Radiation Therapy, Paclitaxel Poliglumex and Cetuximab in Advanced Head and Neck Cancer [Phase 1, Phase 2]
A Phase I/II study evaluating radiation therapy with paclitaxel poliglumex and cetuximab in advanced head and neck cancer has completed.
-
CLINICAL_TRIALS trial_result · 2021-11-01Clinical Trial Update: Benefits of Immunonutrition in Patients With Head and Neck Cancer Receiving Chemoradiation [Phase 2]
Phase 2 clinical trial evaluating immunonutrition benefits in head and neck cancer patients receiving chemoradiation, focusing on oral mucos…
-
CLINICAL_TRIALS trial_result · 2021-10-26Clinical Trial Update: Adaptive Radiotherapy for Head and Neck Cancer [Phase 2]
Phase 2 trial update on adaptive radiotherapy for head and neck cancers completed.
-
CLINICAL_TRIALS trial_result · 2021-09-30Clinical Trial Update: Arginase Inhibitor INCB001158 as a Single Agent and in Combination With Immune Checkpoint Therapy in Patients With Advanced/Metastatic Solid Tumors [Phase 1]
Phase 1 study results for INCB001158, an arginase inhibitor, as a single agent and in combination with immune checkpoint therapy, in patient…
-
CLINICAL_TRIALS trial_result · 2021-09-20Clinical Trial Update: A Study of the Effects of GC4419 on Radiation Induced Oral Mucositis in Patients With Head/Neck Cancer [Phase 2]
Phase 2 study evaluating GC4419 for radiation-induced oral mucositis in head/neck cancer patients has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2021-09-17Clinical Trial Update: Development and Evaluation of Rehabilitation Consult for Survivors of Head and Neck Cancer [NA]
Clinical trial update on rehabilitation consult for survivors of head and neck cancer; study completed with results posted.
-
CLINICAL_TRIALS trial_result · 2021-09-10Clinical Trial Update: Radioprotective Effect of Chinese Herbal Medicine on Oral Mucositis [Phase 2]
Phase 2 clinical trial investigating radioprotective effects of Chinese herbal medicine on oral mucositis in head and neck cancer patients.
-
CLINICAL_TRIALS trial_result · 2021-09-09Clinical Trial Update: Megestrol to Limit Weight Loss and Improve Quality of Life in Treating Patients With Head and Neck Cancer [Phase 3]
Phase 3 trial evaluating megestrol to limit weight loss and improve quality of life in patients with head and neck cancer.
-
CLINICAL_TRIALS trial_result · 2021-08-27Clinical Trial Update: The Effect of Alpha Lipoic Acid on the Incidence and Severity of Radiotherapy-Induced Oral Mucositis in Head and Neck Cancer Patients [Phase 2, Phase 3]
Phase 2 and Phase 3 trial evaluating the effect of alpha lipoic acid on incidence and severity of radiotherapy-induced oral mucositis in hea…
-
CLINICAL_TRIALS trial_result · 2021-07-22Clinical Trial Update: Optimising Radiation Therapy in Head and Neck Cancers Using Functional Image-Guided Radiotherapy and Novel Biomarkers [Phase 1, Phase 2]
A multi-phase clinical trial investigating functional image-guided radiotherapy and novel biomarkers to optimise radiation therapy in head a…
-
CLINICAL_TRIALS trial_result · 2021-07-09Clinical Trial Update: Abemaciclib and Pembrolizumab in Metastatic or Recurrent Head and Neck Cancer [Phase 2]
Phase 2 trial of abemaciclib with pembrolizumab in metastatic or recurrent head and neck cancer was terminated; results posted in 2021.
-
CLINICAL_TRIALS trial_result · 2021-07-09Clinical Trial Update: Perioperative Analgesia Using Gabapentin in Head and Neck Cancer Surgery [Phase 3]
Phase 3 trial on perioperative gabapentin for pain management in head and neck cancer surgery; study terminated with results posted in 2021.
-
CLINICAL_TRIALS trial_result · 2021-07-01Clinical Trial Update: A Volume, Motion, and Anatomically Adaptive Approach to Photon and Proton Beam Radiotherapy [NA]
Clinical trial update describing an adaptive radiotherapy approach using photon and proton beams; results posted after completion.